IMARA files July 2021 corporate presentation on hemoglobin disorder pipeline

Enliven Therapeutics, Inc.

Filed a corporate slide presentation as Exhibit 99.1 under Item 8.01.
Presentation titled 'Advancing Novel Treatments for Hemoglobin Disorders' dated July 2021.
No financial results, guidance, or material operational updates provided.
Routine disclosure of materials used in investor meetings; no new events announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.